Cargando…

Awareness of COVID-19 Symptoms, Risk Factors, and Vaccinations in Patients with Multiple Sclerosis

Multiple Sclerosis (MS) is the most common chronic autoimmune disease of the central nervous system, affecting around 2.8 million people worldwide. Patients’ knowledge about COVID-19 infection, and their proper protective actions, may reduce the risk of infection. The aim of this study was to assess...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krzystanek, Ewa, Jurczak, Agata, Kocur, Kinga, Jurkiewicz, Jakub, Kaczmarczyk, Aleksandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951455/ https://www.ncbi.nlm.nih.gov/pubmed/35329050 http://dx.doi.org/10.3390/ijerph19063366

Ejemplares similares

The Impact of Vitamin D Low Doses on Its Serum Level and Cytokine Profile in Multiple Sclerosis Patients
por: Walawska-Hrycek, Anna, et al.
Publicado: (2021)

Vitamin D Supplementation Practices among Multiple Sclerosis Patients and Professionals
por: Galus, Weronika, et al.
Publicado: (2022)

Kinesiophobia in Stroke Patients, Multiple Sclerosis and Parkinson’s Disesase
por: Wasiuk-Zowada, Dagmara, et al.
Publicado: (2021)

Kinesiophobia in People with Multiple Sclerosis and Its Relationship with Physical Activity, Pain and Acceptance of Disease
por: Wasiuk-Zowada, Dagmara, et al.
Publicado: (2022)

Relationship between Fatigue and Physical Activity in a Polish Cohort of Multiple Sclerosis Patients
por: Rzepka, Michalina, et al.
Publicado: (2020)

Adequate Knowledge of Stroke Symptoms, Risk Factors, and Necessary Actions in the General Population of Southern Poland
por: Krzystanek, Ewa, et al.
Publicado: (2020)

Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors
por: Ajdacic-Gross, Vladeta, et al.
Publicado: (2021)

Affective Disorder and Functional Status as well as Selected Sociodemographic Characteristics in Patients with Multiple Sclerosis, Parkinson’s Disease and History of Stroke
por: Knapik, Andrzej, et al.
Publicado: (2020)

Analysis of Side Effects Following Vaccination Against COVID-19 Among Individuals With Multiple Sclerosis Treated With DMTs in Poland
por: Czarnowska, Agata, et al.
Publicado: (2022)

Awareness of patients with multiple sclerosis in Saudi Arabia regarding the relationship between smoking and multiple sclerosis
por: Kashoo, Faizan Z., et al.
Publicado: (2020)

Awareness of patients with multiple sclerosis in Saudi Arabia regarding the relationship between smoking and multiple sclerosis
por: Bashamakh, Lujain F., et al.
Publicado: (2019)

Partial volume-aware assessment of multiple sclerosis lesions
por: Fartaria, Mário João, et al.
Publicado: (2018)

Symptoms after COVID-19 Infection in Individuals with Multiple Sclerosis in Poland
por: Czarnowska, Agata, et al.
Publicado: (2021)

Epileptiform activity in the acute phase of stroke predicts the outcomes in patients without seizures
por: Lasek-Bal, Anetta, et al.
Publicado: (2023)

Stroke Awareness in Luxemburg: Deficit Concerning Symptoms and Risk Factors
por: Droste, Dirk W, et al.
Publicado: (2014)

Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome
por: Lebrun-Frénay, Christine, et al.
Publicado: (2021)

Young population awareness of head and neck cancer's (HNC) risk factors, symptoms and prognosis – a pilot survey
por: Krentowska, Anna, et al.
Publicado: (2015)

Headache as a symptom of Multiple Sclerosis
por: Kalamatas, T, et al.
Publicado: (2013)

Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies
por: Czarnowska, Agata, et al.
Publicado: (2022)

Case report: First manifestation of multiple sclerosis temporally correlated with COVID-19 vaccination
por: Czarnowska, Agata, et al.
Publicado: (2023)

Tolerogenic vaccines for Multiple Sclerosis
por: Mannie, Mark D., et al.
Publicado: (2013)

Is multiple sclerosis a risk factor for infections?
por: Lechner-Scott, Jeannette, et al.
Publicado: (2020)

Growth Factors and Their Roles in Multiple Sclerosis Risk
por: Lu, Hui, et al.
Publicado: (2021)

The Role of Stress Perception and Coping with Stress and the Quality of Life Among Multiple Sclerosis Patients
por: Kołtuniuk, Aleksandra, et al.
Publicado: (2021)

Illness acceptance degree versus intensity of psychopathological symptoms in patients with psoriasis
por: Kostyła, Magdalena, et al.
Publicado: (2013)

Panic disorder as presenting symptoms of multiple sclerosis
por: Algin, Demet İlhan, et al.
Publicado: (2010)

Jacksonian seizure as the relapse symptom of multiple sclerosis
por: Najafi, Mohammad Reza, et al.
Publicado: (2013)

Yoga as an intervention to manage multiple sclerosis symptoms
por: Thakur, Priyanka, et al.
Publicado: (2020)

Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art
por: Silveira, Celeste, et al.
Publicado: (2019)

The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms
por: Haddad, Fatma, et al.
Publicado: (2022)

Oxidative stress-related risk of the multiple sclerosis development
por: Vasić, Marija, et al.
Publicado: (2023)

Recommendations of the Polish Medical Society of Radiology and the Polish Society of Neurology for the routinely used magnetic resonance imaging protocol in patients with multiple sclerosis
por: Sąsiadek, Marek, et al.
Publicado: (2020)

Depressive Symptoms among Middle-Aged Women—Understanding the Cause
por: Cybulska, Anna M., et al.
Publicado: (2020)

mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis
por: Blanco, Yolanda, et al.
Publicado: (2023)

Awareness of Saudi community toward multiple sclerosis in Qassim Region, Saudi Arabia
por: Al-Hamdan, Nourah A., et al.
Publicado: (2021)

Assessment of Multiple Sclerosis Awareness and Knowledge among the Community of Jeddah, Saudi Arabia
por: Farran, Eyas K., et al.
Publicado: (2021)

Risk factors for fingolimod-induced lymphopenia in multiple sclerosis
por: Ohtani, Ryohei, et al.
Publicado: (2018)

COVID-19 in multiple sclerosis patients and risk factors for severe infection
por: Chaudhry, Farhan, et al.
Publicado: (2020)

Chlorpromazine affects the numbers of Sox-2, Musashi1 and DCX-expressing cells in the rat brain subventricular zone
por: Skałbania, Jakub, et al.
Publicado: (2021)

Vaccination and multiple sclerosis in the era of the COVID-19 pandemic
por: Monschein, Tobias, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_332vnkc3lil81ifcvqdltqo7s5